D2 newsletters from 2021.
How can value demonstration play an important role in pharma market access
How can value demonstration play an important role in pharma market access
How can value demonstration play an important role in pharma market access
Has the Coronavirus put your business at Risk? Many of the companies in the pharmaceutical and bio-pharmaceutical space have products that are manufactured in China or other areas impacted. Has this put your drug’s supply chain at risk? Let D2 and our partners help by aligning you with a North American based CMO that can…
“Time is of the essence”, “Time is money”, “Time isn’t the main thing, it’s the only thing”. There are literally millions of quotes regarding the importance of time. Time isn’t just the driver of how we might measure our quality of life. However, what may be more important is how we manage our time at…
Meeting CMS Requirements As many of you know D2 works with Specialty pharmacies in a variety of arenas, including but not limited to Operations, Licensing, Accreditation and most recently Digital Patient Engagement. As part of our accreditation support, we have helped over 200 entities become accredited and support accreditation in the areas of URAC, ACHC,…
How can value demonstration play an important role in pharma market access
Many years ago, I walked into a hospital pharmacy (yes, in the basement) and the pharmacy director had this phrase in big bold letters on his chalk board: Process + Structure = Outcomes Many years ago, I walked into a hospital pharmacy (yes, in the basement) and the pharmacy director had this phrase in big…
Getting Ahead of the Impact As a part of the Covid-19 crisis we have certainly learned about social distancing, wearing masks, using hand sanitizer and the like. Of course, this is easy if I am walking through Walmart, or taking my dog for a walk. This is much more difficult if I have a work…
The Impact on Virtual Manufacturers An interesting aspect of industry changes is the law of unintended consequences. Such is the impact of the Drug Supply Chain Security Act, (DSCSA). Enacted in 2013 DSCSA has had a dramatic impact on State Licensing requirements for Virtual Manufacturers. In 2015, Virtual Manufacturers were required to have 21 state…
I have previously posted on the potential need to bring drug manufacturing back home. As such I wanted to take the opportunity to share this article regarding our dependency on a foreign drug supply channel. This article provides interesting insights to the dependency of the US on China and India for manufacturing. But also provides…